For example, in BRCA1-deficient breast cancer mice, a model carrying the BRCA1C61G missence mutation were found to have broken the N-terminal RING domain of BRCA1, and be significantly resistant to PARPi [41]. This evidence concerns the gene BRCA1 and breast cancer.